Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunitha Kakarla

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Journal (Sudbury, Mass.)|March 27, 2014
CAR T cells for solid tumors: armed and ready to go?Sunitha Kakarla, Stephen Gottschalk
Cancer Journal (Sudbury, Mass.)|March 27, 2014
Genetic modification of T cellsRichard A Morgan, Sunitha Kakarla
Immunotherapy|December 1, 2012
Cancer-associated fibroblasts as targets for immunotherapySunitha Kakarla, Xiao-Tong Song, Stephen Gottschalk
Plos One|December 19, 2013
A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreadingStephen Gottschalk, Feng Yu, Minjun Ji, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 22, 2014
Engager T cells: a new class of antigen-specific T cells that redirect bystander T cellsKota Iwahori, Sunitha Kakarla, Mireya P Velasquez, et al.
Blood|February 10, 2011
T cells redirected against CD70 for the immunotherapy of CD70-positive malignanciesDonald R Shaffer, Barbara Savoldo, Zhongzhen Yi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stromaSunitha Kakarla, Kevin K H Chow, Melinda Mata, et al.
Scientific Reports|June 4, 2016
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive MalignanciesMireya Paulina Velasquez, David Torres, Kota Iwahori, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 17, 2012
T cells redirected to EphA2 for the immunotherapy of glioblastomaKevin K H Chow, Swati Naik, Sunitha Kakarla, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Journal (Sudbury, Mass.)|March 27, 2014
CAR T cells for solid tumors: armed and ready to go?Sunitha Kakarla, Stephen Gottschalk
Cancer Journal (Sudbury, Mass.)|March 27, 2014
Genetic modification of T cellsRichard A Morgan, Sunitha Kakarla
Immunotherapy|December 1, 2012
Cancer-associated fibroblasts as targets for immunotherapySunitha Kakarla, Xiao-Tong Song, Stephen Gottschalk
Plos One|December 19, 2013
A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreadingStephen Gottschalk, Feng Yu, Minjun Ji, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 22, 2014
Engager T cells: a new class of antigen-specific T cells that redirect bystander T cellsKota Iwahori, Sunitha Kakarla, Mireya P Velasquez, et al.
Blood|February 10, 2011
T cells redirected against CD70 for the immunotherapy of CD70-positive malignanciesDonald R Shaffer, Barbara Savoldo, Zhongzhen Yi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stromaSunitha Kakarla, Kevin K H Chow, Melinda Mata, et al.
Scientific Reports|June 4, 2016
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive MalignanciesMireya Paulina Velasquez, David Torres, Kota Iwahori, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 17, 2012
T cells redirected to EphA2 for the immunotherapy of glioblastomaKevin K H Chow, Swati Naik, Sunitha Kakarla, et al.
Pageof 1